Clinical Trial: A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
Study Status: Completed
Recruit Status: Completed
Condition: Human Papillomavirus Infection
Study Type: Interventional
Official Title: A Phase I Trial in Healthy Chinese Women Ages 18-45 to Evaluate the Safety and Tolerability Profile of Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Esch
Brief Summary:
This study is to evaluate the safety and tolerability profile of Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli) in healthy women ages 18-45
Read more